DK344489D0 - Substituerede 2-imidazoliner og fremstilling og anvendelse deraf - Google Patents

Substituerede 2-imidazoliner og fremstilling og anvendelse deraf

Info

Publication number
DK344489D0
DK344489D0 DK344489A DK344489A DK344489D0 DK 344489 D0 DK344489 D0 DK 344489D0 DK 344489 A DK344489 A DK 344489A DK 344489 A DK344489 A DK 344489A DK 344489 D0 DK344489 D0 DK 344489D0
Authority
DK
Denmark
Prior art keywords
pct
imidazolines
preparation
substituted
sec
Prior art date
Application number
DK344489A
Other languages
English (en)
Inventor
Poul Borrevang
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK344489A priority Critical patent/DK344489D0/da
Publication of DK344489D0 publication Critical patent/DK344489D0/da
Priority to CN90107080A priority patent/CN1049343A/zh
Priority to ZA905422A priority patent/ZA905422B/xx
Priority to IL9504690A priority patent/IL95046A/en
Priority to NZ234451A priority patent/NZ234451A/xx
Priority to EP90912283A priority patent/EP0482108B1/en
Priority to AU61644/90A priority patent/AU637393B2/en
Priority to DK90912283.0T priority patent/DK0482108T3/da
Priority to AT90912283T priority patent/ATE135703T1/de
Priority to DD90342726A priority patent/DD296489A5/de
Priority to DE69026087T priority patent/DE69026087T2/de
Priority to US07/781,269 priority patent/US5262430A/en
Priority to KR1019920700067A priority patent/KR927003578A/ko
Priority to YU136390A priority patent/YU136390A/sh
Priority to JP2511434A priority patent/JPH04506968A/ja
Priority to ES90912283T priority patent/ES2086409T3/es
Priority to CA002064095A priority patent/CA2064095A1/en
Priority to PT94685A priority patent/PT94685B/pt
Priority to GR900100535A priority patent/GR1000716B/el
Priority to PCT/DK1990/000184 priority patent/WO1991000862A1/en
Priority to IE254690A priority patent/IE74210B1/en
Priority to FI920118A priority patent/FI920118A0/fi
Priority to NO92920143A priority patent/NO920143L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Nonmetallic Welding Materials (AREA)
  • External Artificial Organs (AREA)
  • Fertilizers (AREA)
DK344489A 1989-07-12 1989-07-12 Substituerede 2-imidazoliner og fremstilling og anvendelse deraf DK344489D0 (da)

Priority Applications (23)

Application Number Priority Date Filing Date Title
DK344489A DK344489D0 (da) 1989-07-12 1989-07-12 Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
CN90107080A CN1049343A (zh) 1989-07-12 1990-07-11 取代的2-咪唑啉及其制备和用途
ZA905422A ZA905422B (en) 1989-07-12 1990-07-11 Substituted 2-imidazolines and preparation and use thereof
IL9504690A IL95046A (en) 1989-07-12 1990-07-11 Substituted 2-imidazolines and pharmaceutical compositions containing them.
NZ234451A NZ234451A (en) 1989-07-12 1990-07-11 Benzofuran-substituted 2-imidazoline derivatives and pharmaceutical compositions
IE254690A IE74210B1 (en) 1989-07-12 1990-07-12 Substituted 2-imidazolines and preparation and use thereof
DE69026087T DE69026087T2 (de) 1989-07-12 1990-07-12 Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
JP2511434A JPH04506968A (ja) 1989-07-12 1990-07-12 置換された２―イミダゾリンならびにその調製法および使用法
DK90912283.0T DK0482108T3 (da) 1989-07-12 1990-07-12 Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf
AT90912283T ATE135703T1 (de) 1989-07-12 1990-07-12 Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
DD90342726A DD296489A5 (de) 1989-07-12 1990-07-12 Substituierte 2-imidiazol und verfahren und verwendung
EP90912283A EP0482108B1 (en) 1989-07-12 1990-07-12 Substituted 2-imidazolines and preparation and use thereof
US07/781,269 US5262430A (en) 1989-07-12 1990-07-12 Substituted 2-imidazolines and use thereof
KR1019920700067A KR927003578A (ko) 1989-07-12 1990-07-12 치환 2-이미다졸린 및 그 제조방법 그리고 그 이용
YU136390A YU136390A (sh) 1989-07-12 1990-07-12 Postupak za dobijanje supstituisanih 2-imidazolina
AU61644/90A AU637393B2 (en) 1989-07-12 1990-07-12 Substituted 2-imidazolines and preparation and use thereof
ES90912283T ES2086409T3 (es) 1989-07-12 1990-07-12 Imidazolinas sustituidas en posicion 2 y preparacion y uso de las mismas.
CA002064095A CA2064095A1 (en) 1989-07-12 1990-07-12 Substituted 2-imidazolines and preparation and use therof
PT94685A PT94685B (pt) 1989-07-12 1990-07-12 Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
GR900100535A GR1000716B (el) 1989-07-12 1990-07-12 Υποκαταστημενες 2-ιμιδαζολινες και παρασκευη και χρηση αυτων.
PCT/DK1990/000184 WO1991000862A1 (en) 1989-07-12 1990-07-12 Substituted 2-imidazolines and preparation and use thereof
NO92920143A NO920143L (no) 1989-07-12 1992-01-10 Substituerte 2-imidazoliner og fremstilling og anvendelsederav
FI920118A FI920118A0 (fi) 1989-07-12 1992-01-10 Substituerade 2-imidazoliner samt framstaellning och anvaendning av dem.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK344489A DK344489D0 (da) 1989-07-12 1989-07-12 Substituerede 2-imidazoliner og fremstilling og anvendelse deraf

Publications (1)

Publication Number Publication Date
DK344489D0 true DK344489D0 (da) 1989-07-12

Family

ID=8122944

Family Applications (2)

Application Number Title Priority Date Filing Date
DK344489A DK344489D0 (da) 1989-07-12 1989-07-12 Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
DK90912283.0T DK0482108T3 (da) 1989-07-12 1990-07-12 Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90912283.0T DK0482108T3 (da) 1989-07-12 1990-07-12 Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf

Country Status (22)

Country Link
US (1) US5262430A (da)
EP (1) EP0482108B1 (da)
JP (1) JPH04506968A (da)
KR (1) KR927003578A (da)
CN (1) CN1049343A (da)
AT (1) ATE135703T1 (da)
AU (1) AU637393B2 (da)
CA (1) CA2064095A1 (da)
DD (1) DD296489A5 (da)
DE (1) DE69026087T2 (da)
DK (2) DK344489D0 (da)
ES (1) ES2086409T3 (da)
FI (1) FI920118A0 (da)
GR (1) GR1000716B (da)
IE (1) IE74210B1 (da)
IL (1) IL95046A (da)
NO (1) NO920143L (da)
NZ (1) NZ234451A (da)
PT (1) PT94685B (da)
WO (1) WO1991000862A1 (da)
YU (1) YU136390A (da)
ZA (1) ZA905422B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201709A1 (de) * 1992-01-23 1993-07-29 Bayer Ag (alpha)-aryl-(alpha)-hydroxy-ss-imidazolinyl-propionsaeureamide
US5750543A (en) * 1996-02-01 1998-05-12 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US6410562B1 (en) 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds
US20090162342A1 (en) * 2001-06-07 2009-06-25 Sanomune Inc. Therapeutic uses of glandular kallikrein
BRPI0511722A (pt) * 2004-06-01 2008-01-08 Hoffmann La Roche 3-amino-1-arilpropilindóis como inibidores da recaptação de monoamina
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
DK2854841T3 (da) 2012-06-04 2017-05-22 Diamedica Inc Kallikrein-1-glycosyleringsisoformer af humant væv
EP3592377A4 (en) 2017-03-09 2021-02-17 Diamedica Inc. DOSAGE FORMS OF TISSUE KALLIKREIN 1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936885B2 (ja) * 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤
ZW13782A1 (en) * 1981-07-28 1982-10-06 Reckitt & Colmann Prod Ltd Imidazoline derivatives
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
IL95046A (en) 1995-03-15
AU6164490A (en) 1991-02-06
EP0482108A1 (en) 1992-04-29
GR1000716B (el) 1992-11-23
NO920143L (no) 1992-03-04
IE902546A1 (en) 1991-02-27
DE69026087T2 (de) 1996-08-29
DE69026087D1 (de) 1996-04-25
KR927003578A (ko) 1992-12-18
ZA905422B (en) 1991-03-27
FI920118A0 (fi) 1992-01-10
DD296489A5 (de) 1991-12-05
ATE135703T1 (de) 1996-04-15
DK0482108T3 (da) 1996-07-22
IE74210B1 (en) 1997-07-16
NO920143D0 (no) 1992-01-10
CN1049343A (zh) 1991-02-20
IL95046A0 (en) 1991-06-10
PT94685B (pt) 1997-04-30
EP0482108B1 (en) 1996-03-20
PT94685A (pt) 1991-03-20
AU637393B2 (en) 1993-05-27
CA2064095A1 (en) 1991-01-13
WO1991000862A1 (en) 1991-01-24
GR900100535A (en) 1991-12-10
YU136390A (sh) 1993-10-20
ES2086409T3 (es) 1996-07-01
JPH04506968A (ja) 1992-12-03
NZ234451A (en) 1991-08-27
US5262430A (en) 1993-11-16

Similar Documents

Publication Publication Date Title
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
SE8700498D0 (sv) Novel pharmaceologically active compounds
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ES2009723T3 (es) Derivados de acidos biliares, procedimientos para la preparacion de los mismos y composiciones farmaceuticas conteniendolos.
ATE94757T1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
FI972384A (fi) Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-terminaalisia sulfonyyli- tai amidinosulfonyyliryhmiä
NO972623L (no) Farmasöytisk blanding omfattende lamotrigin
DK0386451T3 (da) Oxiderede diphenylheteroalkaner, fremgangsmåde til fremstilling heraf og anvendelsen af disse
DK344489D0 (da) Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
DE69022845T2 (de) Erythromycinderivate.
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
IT8819835A0 (it) Composizione dietetica eprocedimento per la sua preparazione.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DK0539451T3 (da) Vinylsulfonyl-pristinamycin og dets fremstilling
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
IT8819665A0 (it) (1,2_di_0_acetil_glicero_3_fosforil)_colina, procedimento per la sua preparazione e suo uso terapeutico.
ES2116574T3 (es) 4-guanidinobutiramida para mejorar la circulacion de la sangre.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment